Cerevel Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of...
CAMBRIDGE, Mass., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, (Nasdaq: CERE), a company dedicated to unraveling the mysteries of...
Achieved two landmark milestones with OCS-01, Oculis’ lead product candidate as first investigational eye drop for both front and back...
Bioventure Bioventure logo Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership between Alvotech and BioventureAlvotech (NASDAQ:...
- Approval of Adalimumab-EVA™ represents the second biosimilar approval under the strategic partnership between Alvotech and BioventureREYKJAVIK, Iceland and DUBAI,...
Tecentriq subcutaneous (SC) is now approved in Great Britain for all indications of intravenous Tecentriq, including certain types of lung,...
Company Anticipates Read Outs of the Clinical Data from its EU and US Feasibility Studies this September and in Q4BERKELEY,...
Cash balance of $17.5 million as at June 30, 2023Revenue of $1.2 million (vs 2022: $0.8 million, an increase of...
$48.7 million in cash and cash equivalents at June 30, 2023, providing expected runway to advance Company's development candidate ("DC")...
Minimally invasive device reduces intraocular pressure for adults with open angle glaucomaATLANTA--(BUSINESS WIRE)--Georgia Eye Partners is proud to share that...
Eugene, Oregon--(Newsfile Corp. - August 29, 2023) - Silo Wellness, Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) ("SILO") has confirmed...
NEW AND EXTENDED ALLIANCES UNDERLINE PIPELINE VALUE POTENTIALNEW GUIDANCE FOR FULL-YEAR 2023 CONFIRMEDHAMBURG, GERMANY / ACCESSWIRE / August 29, 2023...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, BC / ACCESSWIRE /...
SAN DIEGO--(BUSINESS WIRE)--$MASI #MasimoCorporation--Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons who purchased...
Toronto, Ontario--(Newsfile Corp. - August 28, 2023) - Empatho Holdings Inc. (CSE: EMPH) (formerly, Shane Resources Ltd.) ("Empatho" or the...
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Idiopathic HypersomniaORLANDO, FL / ACCESSWIRE / August...
NORTHAMPTON, MA / ACCESSWIRE / August 28, 2023 / Quest DiagnosticsQuest Diagnostics supported the Health Empowerment and Wellness event hosted...
NORTHAMPTON, MA / ACCESSWIRE / August 28, 2023 / AlkermesEquality for women matters every day, and at Alkermes we're proud...
LAS VEGAS, NV / ACCESSWIRE / August 28, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNHF) ("Planet 13" or the "Company"),...
State-of-the-Art Clinic Expands Allergy Testing and Treatment from Online-Only to Hybrid With Brick and Mortar Presence, While New Medical Executives...
USA master distribution for leader in odor remediation servicesBONITA SPRINGS, FL / ACCESSWIRE / August 28, 2023 / (OTC PINK:MGON)...